How much does a box of ibrutinib currently cost and where to buy it?
Ibrutinib, also known as ibrutinib, is an oral Bruton's tyrosine kinase (BTK) inhibitor that is widely used to treat hematological malignancies such as chronic lymphocytic leukemia and mantle cell lymphoma. At present, ibrutinib has been officially launched in China and has been successfully included in the medical insurance system, providing patients with more convenient drug purchase channels and financial support.
In the domestic market, the price of ibrutinib is relatively high, with a box costing about 8,000 yuan. Specific prices and medical insurance reimbursement ratios vary by region and hospital. Patients can consult the local hospital pharmacy for detailed reimbursement policies and actual payment amounts. Although the price is relatively high, the inclusion of medical insurance has greatly reduced the financial burden on patients, allowing more patients to obtain standardized treatment.

In addition, there are various specifications of ibrutinib generic drugs in overseas markets, and the prices are generally more affordable. For example, generic drugs of 140mg specifications of 120 capsules or 112 capsules are priced at 1,000 RMB, which is much lower than domestic original drugs. The price of the version produced by Beacon Pharmaceuticals in some countries, such as Bangladesh, is relatively high, about 4,000 yuan, but it is still much cheaper than the domestic price, making it an option for some patients to purchase through overseas channels.
Overall, ibrutinib has abundant drug purchase channels at home and abroad. When choosing to purchase, patients should consider their own financial situation and medication needs, and give priority to purchasing drugs through formal channels to ensure medication safety. At the same time, it is recommended that patients actively consult doctors and pharmacists to learn about the latest medical insurance policies and generic drug information in order to make the most suitable treatment decision for them.
Reference materials:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)